Pharmaceutical composition comprising tadalafil or pharmaceuticallly acceptable salt thereof and dutasteride or pharmaceuticallly acceptable salt thereof exhibiting novel dissolution rate
US-2024075028-A1 · Mar 7, 2024 · US
US2020170952A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2020170952-A1 |
| Application number | US-201816618011-A |
| Country | US |
| Kind code | A1 |
| Filing date | May 31, 2018 |
| Priority date | Jun 1, 2017 |
| Publication date | Jun 4, 2020 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A preparation comprised of one or more pellets having an outer shell and core. The outer shell is made of dissolvable material and said core containing poly (ethylene glycol).
Opening claim text (preview).
What is claimed is: 1 . A preparation comprising: a pellet having an outer shell and core, said outer shell made of a dissolvable material and said core containing PEG-3350. 2 . The preparation of claim 1 wherein said dissolvable material is a hydrogel. 3 . The preparation of claim 2 wherein said hydrogel is composed of chitosan and alginate. 4 . The preparation of claim 2 wherein said hydrogel is composed of chitosan and alginate which are cross-linked to encapsulate the PEG-3350. 5 . The preparation of claim 1 wherein the preparation is pH responsive. 6 . The preparation of claim 1 wherein the preparation is pH responsive at a pH of 1-3. 7 . The preparation of claim 4 further including a plurality of pellets, each of said pellet contains 17 g of PEG 3350, sulfate, 0.518 g of sodium bicarbonate, 0.451 g of sodium chloride, and 0.228 g of potassium chloride. 8 . The preparation of claim 4 wherein the preparation is configured to form a mesh, said mesh swells at a pH of 1-3 to release said PEG-3350 from said core. 9 . The preparation of claim 8 wherein the preparation releases said PEG-3350 as the hydrogel swells and the mesh widens causing said PEG-3350 to be released from said core. 10 . A preparation comprising: a pellet having an outer shell and core, said outer shell made of a dissolvable material and said core containing poly(ethylene glycol). 11 . The preparation of claim 10 wherein said dissolvable material is a hydrogel. 12 . The preparation of claim 11 wherein said outer shell of said hydrogel is composed of chitosan and alginate. 13 . The preparation of claim 11 wherein said outer shell of the hydrogel is composed of chitosan and alginate which are cross-linked to encapsulate said poly(ethylene glycol). 14 . The preparation of claim 10 wherein the preparation is pH responsive. 15 . The preparation of claim 10 wherein the preparation is pH responsive at a pH of 1-3. 16 . The preparation of claim 13 further including a plurality of pellets, each of said pellet contains 17 g of poly(ethylene glycol), sulfate, 0.518 g of sodium bicarbonate, 0.451 g of sodium chloride, and 0.228 g of potassium chloride. 17 . The preparation of claim 13 wherein the preparation is configured to swell at a pH of 1-3 to release said poly(ethylene glycol) from said core. 18 . The preparation of claim 17 wherein the preparation releases said poly(ethylene glycol) as the hydrogel swells and the mesh widens causing said poly(ethylene glycol) to be released from said core. 19 . A method of bowel preparation for colonoscopies comprising the steps of: administering an effective amount of a preparation, said preparation comprising a pellet having an outer shell and core, said outer shell made of a dissolvable material and said core containing poly(ethylene glycol). 20 . The method of claim 19 wherein said dissolvable material is a hydrogel and said preparation releases said poly(ethylene glycol) as said hydrogel swells and a mesh formed by said hydrogel widens causing said poly(ethylene glycol) to be released from said core. 21 . The method of claim 20 further including the step of administering an effective amount of a liquid that triggers the swelling of the mesh formed by said hydrogel. 22 . The method of claim 20 further including the step of administering an effective amount of a liquid having a pH that triggers the swelling of the mesh formed by said hydrogel.
Medicinal preparations containing inorganic active ingredients · CPC title
Polysaccharides, e.g. gums, alginate; Cyclodextrin · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers · CPC title
Alkali metal chlorides; Alkaline earth metal chlorides · CPC title
Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.